Skip to main content



Oral Communication

Oral Communication

  • Saturday, June 24, 2023
  • 13:00 – 14:15 ET
    OC 01 - Management of Pulmonary Embolism

    Moderator: Francis Couturaud, PhD – Centre Hospitalo-Universitaire de Brest, Département de Médecine Interne et Pneumologie, INSERM U1304, CIC INSERM 1412, Univ_Brest, Brest, FCRIN INNOVTE, France.

    Moderator: David Jimenez, PhD – Hospital Ramon y Cajal

  • 13:00 – 14:15 ET
    OC 02 - Bleeding and Neonatal Alloimmune Thrombocytopenia in Pregnancy

    Moderator: Renee Eslick, BMed FRACP FRCPA – Canberra Hospital

    Moderator: Peter H. Cygan, MD – Penn State Health Milton S. Hershey Medical Center

  • 13:00 – 14:15 ET
    OC 03 - Cerebrovascular Disease: Bench to Bedside

    Moderator: Mary Cushman, MD, MSc – Department of Medicine, Larner College of Medicine at the University of Vermont, USA

    Moderator: Robert A. Campbell, PhD – University of Utah, Salt Lake City, UT, USA; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA

  • 13:00 – 14:15 ET
    OC 04 - Hemophilia Basic Science - FVIII and FIX

    Moderator: Steven W. Pipe, MD – University of Michigan, Ann Arbor, MI, USA

    Moderator: Orla Rawley, PhD – Queen's University, Pathology and Molecular Medicine

  • 13:00 – 14:15 ET
    OC 05 - Risk Factors and Treatment in COVID-19

    Moderator: Ryan Zarychanski, MD, MSc, FRCPC – University of Manitoba

    Moderator: Vicky Tagalakis, MD MSc – McGill University

  • 13:00 – 14:15 ET
    OC 06 - Management of Acquired Bleeding

    Moderator: Pratima Chowdary, MD – Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, United Kingdom

    Moderator: Rungrote Natesirinilkul, MD – Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

  • 13:00 – 14:15 ET
    OC 07 - Rare Bleeding Disorders I

    Moderator: Roseline d'Oiron, MD – Centre for Haemophilia and Rare Congenital Bleeding Disorders, Bicêtre Hospital AP-HP, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bicêtre, France

    Moderator: Joel Livingston, MSc, MD, FRCPC – Stollery Children's Hospital / The University of Alberta

  • 13:00 – 14:15 ET
    OC 08 - Von Willebrand Disease and Thrombotic Thrombocytopenic Purpura (TTP) Novel Treatments

    Moderator: Paula James, MD – Department of Medicine, Queen's University, Kingston, ON, Canada

    Moderator: Dearbhla Doherty, MD – Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland

  • 13:00 – 14:15 ET
    OC 09 - Novel Insights in Thrombosis

    Moderator: Catherine A. Lemarie, PhD – Department of internal medicine and chest diseases, INSERM U1304_GETBO, Univ_Brest, CHU_Brest, Brest, France

    Moderator: David Smadja, PhD – Université Paris Cité

  • 13:00 – 14:15 ET
    OC 10 - Mechanisms Regulating Vessel Wall Function and Integrity

    Moderator: Hugo ten Cate, MD, PhD, FAHA – Thrombosis Expertise Center, Heart & Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands

    Moderator: Jamie O'Sullivan, PhD – Royal College of Surgeons in Ireland, Irish Centre for Vascular Biology, Dublin, Ireland

  • Sunday, June 25, 2023
  • 10:45 – 12:00 ET
    LB 01 - Late-Breakthrough Session I
  • 10:45 – 12:00 ET
    OC 11 - Diagnosis of Venous Thromboembolism

    Moderator: Maria CECILIA Guillermo Esposito, MD – Unidad Academica de Hematologia, Hospitla de Clinicas, Facultad de Medicina, Universidad de la República.

    Moderator: Gregoire Le Gal, MD PhD – Ottawa Hospital Research Institute, University of Ottawa, Canada

  • 10:45 – 12:00 ET
    OC 12 - Hemophilia Clinical – MSK and Outcomes

    Moderator: Cedric Hermans, MD, PhD – St-Luc University Hospital

    Moderator: Linda Sun, MD MHSc – University of Alberta

  • 10:45 – 12:00 ET
    OC 13 - von Willebrand Factor Biology

    Moderator: Colin Kretz, PhD – McMaster University

    Moderator: Cecile V. Denis, PhD – INSERM

  • 10:45 – 12:00 ET
    OC 14 - Thrombotic Thrombocytopenic Purpura (TTP) Treatment

    Moderator: Kazuya SAKAI, MD, PhD – Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk

    Moderator: Christopher J. Patriquin, MD, MSc, FRCPC – Division of Hematology, University Health Network

  • 10:45 – 12:00 ET
    OC 15 - Towards Improved Assessment of Hemostasis

    Moderator: Emmanuel J. Favaloro, PhD – NSW Health Pathology

    Moderator: Silmara de Lima Montalvao, PhD – University of Campinas - UNICAMP, São Paulo - Brazil

  • 10:45 – 12:00 ET
    OC 16 - Cardiovascular Disease and Prevention

    Moderator: Nels C. Olson, PhD, MPH – Larner College of Medicine, University of Vermont

    Moderator: Luisa Weiss, BSc, MSc, PhD – School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland

  • 10:45 – 12:00 ET
    OC 17 - Genetics of Venous Thromboembolism

    Moderator: Pierre Morange

    Moderator: Astrid van Hylckama Vlieg, PhD – Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands

  • 10:45 – 12:00 ET
    OC 18 - Modulators of Platelet Function

    Moderator: Marie Hollenhorst, MD PhD – Brigham and Women's Hospital, Harvard Medical School

    Moderator: Marie Lordkipanidzé, B.Pharm, PhD – Faculty of pharmacy, University of Montreal

  • 10:45 – 12:00 ET
    OC 19 - Signaling Pathways Regulating Vascular Function

    Moderator: Heyu Ni, MD, PhD – Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

    Moderator: Nadim Tawil, PhD – Research Institute of the McGill University Health Center

  • 14:45 – 16:00 ET
    OC 20 - Hemophilia Gene Therapy for Hemophilia A

    Moderator: Margareth C. Ozelo, MD, PhD – Hemocentro UNICAMP, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

    Moderator: Paul Batty, MBBS, PhD – University College London

  • 14:45 – 16:00 ET
    OC 21 - Management of Venous Thromboembolism I

    Moderator: Patricia Casais, MD, PhD, MSc – University of Buenos Aires, Argentina

    Moderator: Noel Chan, FRACP, FRCPA – Department of Medicine, McMaster University, Hamilton, ON

  • 14:45 – 16:00 ET
    OC 22 - Pathogenesis of COVID-19 Coagulopathy

    Moderator: Mark Blostein, MDCM – Jewish General Hospital

    Moderator: Patricia Liaw, PhD – McMaster University - The Thrombosis & Atherosclerosis Research Institute

  • 14:45 – 16:00 ET
    OC 23 - Engineering Platelets to Work for Us in Diagnosis and Treatment

    Moderator: Christian Kastrup, PhD – Versiti Blood Research Institute

    Moderator: Imane Boukhatem, MSc – Faculty of pharmacy, University of Montreal

  • 14:45 – 16:00 ET
    OC 24 - Hemophilia Clinical – Factor Levels and Pharmacokinetics

    Moderator: Courtney Thornburg, MD, MS – Rady Children's Hospital-San Diego

    Moderator: Guy Young, MD – Children's Hospital Los Angeles

  • 14:45 – 16:00 ET
    OC 25 - The Impact of Coagulation on Peripartum Outcomes

    Moderator: Anandi Krishnan, PhD – Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

    Moderator: Sarah Kelliher, MB – UCD Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin, Ireland

  • 14:45 – 16:00 ET
    OC 26 - Thrombotic Thrombocytopenic Purpura (TTP): Molecular and Clinical

    Moderator: Karen Vanhoorelbeke, PhD – KU Leuven

    Moderator: Konstantine Halkidis, MD, PhD – KUMC

  • 14:45 – 16:00 ET
    OC 27 - Megakaryocyte Biology

    Moderator: Genevieve Pepin, PhD, MBA – Université Du Québec à Trois-RIvières

    Moderator: Robert A. Campbell, PhD – University of Utah, Salt Lake City, UT, USA; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA

  • 14:45 – 16:00 ET
    OC 28 - Factor XIII and Fibrinogen

    Moderator: Verena Schroeder, PhD – University of Bern

    Moderator: Munira Borhany, MBBS, MCPS, FCPS, FRCP (Edin), FRCPath – Haemophilia Welfare Society, Karachi

  • 14:45 – 16:00 ET
    OC 29 - Clinical Outcomes in COVID-19

    Moderator: Lisa Baumann Kreuziger, MD, MS – Versiti Blood Research Institute, Versiti, Milwaukee, WI, USA

    Moderator: Behnood Bikdeli – Brigham and Women's Hospital, Harvard Medical School

  • Monday, June 26, 2023
  • 10:45 – 12:00 ET
    OC 30 - Hemophilia Gene Therapy Basic Science

    Moderator: David Lillicrap, MD – Department of Pathology and Molecular Medicine, Queen's University

    Moderator: Radek Kaczmarek, PhD – Department of Pediatrics, Indiana University School of Medicine

  • 10:45 – 12:00 ET
    OC 31 - DOAC Reversal: Current Practice and Emerging Concepts

    Moderator: Yesim G. Dargaud, MD, PhD – University Lyon 1

    Moderator: Lacra Ivanciu, PhD – University of Pennsylvania/Children's Hospital of Philadelphia

  • 10:45 – 12:00 ET
    OC 32 - Prevention of Venous Thromboembolism

    Moderator: Eilleen G. Merriman, MBChB, PhD, BMLSc – North Shore Hospital

    Moderator: Ana Thereza Rocha, MD, PhD, MHS, FCCP – Universidade Federal da Bahia, Escola Bahiana de Medicina e Saude Publica

  • 10:45 – 12:00 ET
    OC 33 - Hemophilia Basic Science - Novel Therapies and Joint Disease

    Moderator: Jean St-Louis, MD, FRCPC – Université de Montréal

    Moderator: Jordan A. Shavit, MD, PhD – Department of Pediatrics and Department of Human Genetics, University of Michigan Medical School

  • 10:45 – 12:00 ET
    OC 34 - Post-Thrombotic Syndrome

    Moderator: Joseph R. Shaw, MD – The Ottawa Hospital

    Moderator: Anat Rabinovich, MD – Soroka University Medical Center

  • 10:45 – 12:00 ET
    OC 35 - Hemostatic Balance and Anticoagulants in Women’s Health

    Moderator: Fionnuala Ni Ainle, MD, PhD – University College Dublin

    Moderator: Camille Simard, MDCM, MSc – McGill University

  • 10:45 – 12:00 ET
    OC 36 - Venous Thromboembolism Risk Prediction in Cancer Patients

    Moderator: Tzu-Fei Wang, MD, MPH – Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Moderator: Alok A. Khorana, MD – Cleveland Clinic and Case Comprehensive Cancer Center

  • 10:45 – 12:00 ET
    OC 37 - Fibrinolysis and Proteolysis

    Moderator: Robert L. Medcalf, PhD – Monash University

    Moderator: Lauren Poole, PhD – Rutgers University Robert Wood Johnson Medical School, Department of Pharmacology

  • 10:45 – 12:00 ET
    OC 38 - Acquired Prothrombotic States in Children

    Moderator: Suchitra Acharya, MD – Cohen Children’s Medical Center, Northwell Health

    Moderator: Irene Klaassen, MD PhD – Amsterdam UMC

  • 10:45 – 12:00 ET
    OC 39 - Platelet Production from Megakaryocytes

    Moderator: Kellie Machlus, PhD – Boston Children's Hospital

    Moderator: Eric Boilard, PhD – Centre de Recherche du CHU de Québec- Université Laval

  • 14:45 – 16:00 ET
    OC 40 - Management of Venous Thromboembolism II

    Moderator: ZOUBIDA TAZI MEZALEK, MD – Internal medicine - Clinical Hematology. Faculty of medicine.University Mohamed V. Rabat.Morocco

    Moderator: Erik Klok, MD, PhD, FESC – Leiden University Medical Center

  • 14:45 – 16:00 ET
    OC 41 - Contact Pathway: Structure and Function I

    Moderator: Joost C.M Meijers, PhD – Department of Experimental Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands

    Moderator: Bassem M. Mohammed, BPharm, PhD – Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine

  • 14:45 – 16:00 ET
    OC 42 - Immune-Mediated Thrombocytopenic Disorders

    Moderator: Allyson Pishko, MD – University of Pennsylvania

    Moderator: Margaret N. Warner, Associate Professor, Department of Medicine, Faculty of Medicine, McGill University – McGill University Health Center

  • 14:45 – 16:00 ET
    OC 43 - Hemophilia Clinical - Factor VIII Mimetics

    Moderator: Mark Belletrutti, MD MSc FRCPC – BC Children's Hospital, University of British Columbia

    Moderator: Caterina Casari, PhD – Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixte de Recherche S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay

  • 14:45 – 16:00 ET
    OC 44 - Hemophilia Basic Science - Inhibitors

    Moderator: Margaret V. Ragni, MD, MPH – Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

    Moderator: Davide Matino, MD – Department of Medicine, Division of Hematology, McMaster University, Hamilton, ON

  • 14:45 – 16:00 ET
    OC 45 - Integrating Knowledge on Coagulation

    Moderator: Stephanie  A. Smith, DVM – University of Michigan

    Moderator: Yaqiu Sang, PhD – UNC at Chapel Hill

  • 14:45 – 16:00 ET
    OC 46 - Molecular Insights in Cancer Associated Thrombosis

    Moderator: Corinne Frere, MD, PhD – AP.HP Sorbonne Université

    Moderator: Atsushi Yamashita, MD, PhD – University of Miyazaki

  • 14:45 – 16:00 ET
    OC 47 - Mechanisms of Thromboinflammation

    Moderator: David Stegner, PhD – Institute of Experimental Biomedicine - Chair I, University Hospital and Rudolf Virchow Center for Integrative and Translational Bioimaging, Würzburg, Germany

    Moderator: Benjamin Tourdot, PhD – Cincinnati Children's Hospital

  • 14:45 – 16:00 ET
    OC 48 - The Spectrum of Pediatric Bleeding and Clotting: From Genes to Long-Term Related Outcomes

    Moderator: Bryce A. Kerlin, MD, FAAP – Division of Hematology/Oncology/BMT, Nationwide Children's Hospital

    Moderator: Joel Livingston, MSc, MD, FRCPC – Stollery Children's Hospital / The University of Alberta

  • 14:45 – 16:00 ET
    OC 49 - Mechanisms of Cardiovascular and Neurologic Diseases

    Moderator: Alexandros D. Tselepis, MD, PhD – Atherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece

    Moderator: Erin H. Norris, PhD – The Rockefeller University

  • Tuesday, June 27, 2023
  • 10:45 – 12:00 ET
    LB 02 - Late-Breakthrough Session II
  • 10:45 – 12:00 ET
    OC 50 - Hemophilia Clinical - Inhibitors

    Moderator: Samantha Gouw, MD, PhD – The University of Amsterdam

    Moderator: Lynn Malec, MD, MSc – Versiti Blood Research Institute, Milwaukee, WI, USA; Division of Hematology & Oncology, Departments of Medicine and Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA

  • 10:45 – 12:00 ET
    OC 51 - Regulation of Coagulation in Critical Illness

    Moderator: Jean M. Connors, MD – Brigham and Women's Hospital

    Moderator: Cindy MM De Jong, MD – Department of Medicine - Thrombosis & Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  • 10:45 – 12:00 ET
    OC 52 - Hemophilia Gene Therapy for Hemophilia B

    Moderator: Lindsey A. George, MD – University of Pennsylvania

    Moderator: Johnny Mahlangu, MBBCH, MMed – University of the Witwatersradn

  • 10:45 – 12:00 ET
    OC 53 - Fibrinolysis and Novel Strategies

    Moderator: Ze Zheng, PhD – Medical College of Wisconsin, Versiti Blood Research Institute

    Moderator: Cedric Duval, PhD – University of Leeds

  • 10:45 – 12:00 ET
    OC 54 - Outcomes in Patients with Cancer Associated Thrombosis I

    Moderator: Vicky Tagalakis, MD MSc – McGill University

    Moderator: Federico Germini, MD, MSc, PhD – Department of Medicine, McMaster University, Hamilton, ON

  • 10:45 – 12:00 ET
    OC 55 - Pathological Immunothrombosis

    Moderator: Matthew D. Neal, MD FACS – University of Pittsburgh

    Moderator: Denisa Wagner, PhD – Boston Children's Hospital/Harvard Medical School

  • 10:45 – 12:00 ET
    OC 56 - Hemostatic Mechanisms in Cancer and Autoimmunity

    Moderator: Marina Marchetti, PhD – Department of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy

    Moderator: Wolfram Ruf, MD – University Medicine of the Johannes Gutenberg University Mainz, Center for Thrombosis and Hemostasis (CTH)

  • 10:45 – 12:00 ET
    OC 57 - High Throughput Methods for Improved Understanding of Coagulation and Bleeding

    Moderator: Jill M. Johnsen, MD – University of Washington, Institute for Stem Cell and Regenerative Medicine, Seattle, WA, USA

    Moderator: Laura Raffield, PhD – University of North Carolina Chapel Hill

  • 10:45 – 12:00 ET
    OC 58 - Platelet Signaling

    Moderator: Peisong Ma, PhD – Thomas Jefferson University

    Moderator: Georges JOURDI, PharmD, PhD – Université Paris Cité and APHP. Nord

  • 14:45 – 16:00 ET
    OC 59 - Hemophilia - Novel Therapies I (anti-TFPI)

    Moderator: Maria Elisa Mancuso, MD, PhD – IRCCS Humanitas Research Hospital

    Moderator: Soumitra  Tole, MD MSc FRCPC – Children's Hospital, London Health Science Centre; Western University

  • 14:45 – 16:00 ET
    OC 60 - von Willebrand Disease (VWD) Clinical

    Moderator: Ferdows Atiq, MD, MSc, PhD – Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland

    Moderator: Ross Baker, MD – Health Futures Institute, Murdoch University, Perth, Australia

  • 14:45 – 16:00 ET
    OC 61 - Manipulating Platelet Function

    Moderator: Beatrice Hechler, PhD – Sante FR

    Moderator: Dianne E. Van Der Wal, PhD – R&D Australian Red Cross Lifeblood

  • 14:45 – 16:00 ET
    OC 62 - Novel Antithrombotic Strategies

    Moderator: Georges JOURDI, PharmD, PhD – Université Paris Cité and APHP. Nord

    Moderator: Deborah M. Siegal, MD MSc FRCPC – The Ottawa Hospital

  • 14:45 – 16:00 ET
    OC 63 - Epidemiology of Venous Thromboembolism I

    Moderator: Sigrid Braekkan, PhD – UiT - Arctic University of Norway

    Moderator: Alexander  T. Cohen, MBBS MSc MD FRACP FESC FRCP – Guy's and St Thomas' Hospitals NHS Trust